DocGo Inc. (NASDAQ:DCGO – Get Free Report) has earned a consensus recommendation of “Hold” from the six analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $2.3750.
Several research analysts recently issued reports on DCGO shares. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Canaccord Genuity Group dropped their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 25th. Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th.
View Our Latest Report on DCGO
DocGo Stock Performance
DocGo (NASDAQ:DCGO – Get Free Report) last issued its quarterly earnings data on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.10). The company had revenue of $75.55 million during the quarter, compared to analysts’ expectations of $72.48 million. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%. Sell-side analysts predict that DocGo will post -0.12 earnings per share for the current year.
Institutional Trading of DocGo
Institutional investors and hedge funds have recently modified their holdings of the business. Neuberger Berman Group LLC bought a new position in shares of DocGo during the 4th quarter valued at $29,000. Cerity Partners LLC bought a new stake in DocGo during the second quarter valued at approximately $37,000. Public Employees Retirement System of Ohio purchased a new stake in DocGo during the fourth quarter valued at approximately $40,000. Engineers Gate Manager LP purchased a new stake in DocGo during the second quarter valued at approximately $52,000. Finally, Jain Global LLC bought a new stake in DocGo during the fourth quarter valued at about $70,000. Institutional investors own 56.44% of the company’s stock.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Read More
- Five stocks we like better than DocGo
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
